Abiopharma

🔍 MIONIS ROBERT (Executive)

Company: CELESTICA INC (CLS)

Report Date: 2026-07-31

Detailed Transactions and Holdings:

• Sold 340 shares of Common Shares at $360.47 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 60,044.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 67 shares of Common Shares at $361.11 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 59,977.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,136 shares of Common Shares at $363.14 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 58,841.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 1,640 shares of Common Shares at $364.47 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 57,201.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 40 shares of Common Shares at $365.0 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 57,161.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 660 shares of Common Shares at $366.48 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 56,501.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 2,280 shares of Common Shares at $368.86 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 54,221.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 2,837 shares of Common Shares at $370.02 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 51,384.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 223 shares of Common Shares at $372.46 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 51,161.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 240 shares of Common Shares at $373.6 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 50,921.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 80 shares of Common Shares at $374.49 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 50,841.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-07-31 | Code: H | shares_owned_after: 453,697.00
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-07-31 | Code: H | nature_of_ownership: By Mionis 2026 GRAT Number One | shares_owned_after: 210,445.00
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-07-31 | Code: H | nature_of_ownership: By Mionis 2026 GRAT Number Two | shares_owned_after: 145,565.00

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 11, 2026.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.00-$360.88, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.95-$363.62, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.99-$364.83, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.40-$366.71, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.48-$369.41, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $369.51-$370.45, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.31-$372.84, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.44-$374.42, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.